在非酒精性脂肪肝疾病中的肠道微生物群
Anastasios Mpountouridis1, Christina Tsigalou2, Ioanna Bezirtzoglou3
1Gastroenterology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Frontiers in gastroenterology (Lausanne, Switzerland)
|March 13, 2026
概括
肠道失调,肠道细菌的不平衡,显着导致非酒精性脂肪肝疾病 (NAFLD) 的发展. 像益生菌和益生菌这样的干预措施在通过调节肠道微生物群来管理NAFLD方面表现有前途.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 代谢疾病 代谢疾病
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 影响全球三分之一的人口,其致病因涉及肠道失调.
- 肠道微生物组通过肠肝轴影响肠道屏障完整性和肝脏免疫功能.
- 肠道微生物群的变化,包括细菌群和代谢物的变化,与NAFLD进展有关.
研究的目的:
- 探索肠道微生物组在NAFLD的发展和进展中的多方面的作用.
- 审查肠道微生物群对宿主稳定,肠道屏障功能和肝炎的影响.
- 讨论针对NAFLD管理的肠道微生物组的潜在治疗策略.
主要方法:
- 审查有关肠道微生物组和NAFLD的现有文献.
- 分析包括脂聚糖 (LPS) 转移,胆酸代谢和短链脂肪酸 (SCFA) 生产的途径.
- 检查细菌变化 (例如, Bacteroidetes, Firmicutes) 和它们与NAFLD的关联.
主要成果:
- 肠道功能失调通过增加LPS,改变胆酸代谢 (影响FXR和TGR5信号),以及降低酸盐等SCFA导致NAFLD.
- 在NAFLD患者中观察到特定的细菌变化,如增加的Bacteroidetes和减少的Firmicutes.
- 益生菌,益生菌和协生菌在NAFLD预防和治疗方面具有潜力,而便微生物群移植 (FMT) 需要进一步评估.
结论:
- 肠道微生物组是NAFLD病变的关键因素,影响肝脏脂肪,炎症和纤维化.
- 通过益生菌,益生菌和协生菌调节肠道微生物组为NAFLD提供了有前途的治疗途径.
- 需要进一步的研究,以充分阐明在NAFLD管理中像FMT这样的干预措施的有效性.
相关概念视频
Bacterial Flora of the Large Intestine
1.8K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.8K
Ultrasound II: Endoscopic Ultrasound and FibroScan
983
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
983
What is Monogastric Digestion?
77.0K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
77.0K
Diseases of the Liver and Gallbladder
2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Overview of Fatty Acid Metabolism
37.6K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.6K


